These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18348245)

  • 41. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal.
    Klein E; Uhde TW; Post RM
    Am J Psychiatry; 1986 Feb; 143(2):235-6. PubMed ID: 2868666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Benzodiazepines tolerance and dependence: a case report].
    Bernik MA; Gorenstein C; Tavares SM; Gentil Filho V
    AMB Rev Assoc Med Bras; 1989; 35(5):207-10. PubMed ID: 2577244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregabalin as adjunctive therapy in benzodiazepine discontinuation.
    Caniff K; Telega E; Bostwick JR; Gardner KN
    Am J Health Syst Pharm; 2018 Jan; 75(2):67-71. PubMed ID: 29317396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
    Bech P
    Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The benzodiazepines use disorder].
    Kawano T; Inada K
    Nihon Rinsho; 2015 Sep; 73(9):1506-10. PubMed ID: 26394512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders.
    Michelini S; Cassano GB; Frare F; Perugi G
    Pharmacopsychiatry; 1996 Jul; 29(4):127-34. PubMed ID: 8858711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-adrenergic blocking drugs in anxiety and stress.
    Noyes R
    Psychiatr Clin North Am; 1985 Mar; 8(1):119-32. PubMed ID: 2859576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pregabalin for the treatment of generalised anxiety disorder.
    Montgomery SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2139-54. PubMed ID: 17020438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pregabalin can cause addiction and withdrawal symptoms].
    Nordgaard J; Jürgens G
    Ugeskr Laeger; 2015 Jan; 177(2A):38-9. PubMed ID: 25612958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benzodiazepines--misuse, abuse and dependency.
    Laux G; Puryear DA
    Am Fam Physician; 1984 Nov; 30(5):139-47. PubMed ID: 6149682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The problems with the use of benzodiazepines in elderly patients].
    Bourin M
    Encephale; 2010 Sep; 36(4):340-7. PubMed ID: 20850606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benzodiazepine discontinuation in generalized anxiety disorder.
    Gupta R; Gupta N; Avasthi A
    Am J Psychiatry; 2002 Feb; 159(2):321-2. PubMed ID: 11823290
    [No Abstract]   [Full Text] [Related]  

  • 57. Benzodiazepines as anxiolytic agents: the risks of long-term treatment.
    Mackler SA; Schweizer E
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):109-12, 115-6. PubMed ID: 1355775
    [No Abstract]   [Full Text] [Related]  

  • 58. Pregabalin for alcohol dependence: a critical review of the literature.
    Guglielmo R; Martinotti G; Clerici M; Janiri L
    Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of long-term benzodiazepine medication. A prospective cohort study: methodological and clinical aspects.
    Nyström C
    Nord J Psychiatry; 2005; 59(6):492-7. PubMed ID: 16316903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Withdrawing Benzodiazepines in Patients With Anxiety Disorders.
    Lader M; Kyriacou A
    Curr Psychiatry Rep; 2016 Jan; 18(1):8. PubMed ID: 26733324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.